In patients with COVID-19, NLRP3 inflammasome activation and its dependent caspase-1 and GSDMD cleavage as well as subsequently IL-1β secretion have been demonstrated, suggesting that NLRs and inflammasome sensors are involved in SARS-CoV-2 infection as well (29–31). This evidence concerns the gene IL1B and COVID-19.